Current role
Keith Lane
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Keith Lane
Kiora Pharmaceuticals Inc reported in an 8-K filed September 8, 2026 that Keith Lane was appointed Executive Vice President, Head of Clinical Development and Regulatory Affairs, effective September 8, 2026.
“On September 8, 2026 (the “Effective Date”), Kiora Pharmaceuticals Inc. (the “Company”) appointed Keith Lane as Executive Vice President, Head of Clinical Development and Regulatory Affairs of the Company, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kiora Pharmaceuticals Inc (KPRX)
SEC 8-K
Current2026-09-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kiora Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Brian M. Strem CEO, Board Member
- Brian M. Strem, Ph.D. CEO, CFO, Board Member
- Praveen Tyle Chairman, Board Member
- Praveen Tyle, Ph.D. Chairman, Board Member
- Stephen From Chairman
- Melissa Tosca CFO
- Michael Meluzio, CPA CFO
- Susan L. Drexler CFO, Chief Accounting Officer
- Aron Shapiro Board Member
- Carmine Stengone Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.